This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Universitatsklinikum Heidelberg. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Mircea Iancu: Innovator in Immunosuppressive Blood Cell Technology
Introduction
Mircea Iancu is a notable inventor based in Mannheim, Germany. He has made significant contributions to the field of immunology, particularly in the development of methods for producing immunosuppressive blood cells. His work is crucial for advancing treatments for various autoimmune diseases.
Latest Patents
Mircea Iancu holds a patent for "Immunosuppressive blood cells and methods of producing the same." This invention focuses on a method of producing immunosuppressive blood cells that can be utilized in the treatment of autoimmune diseases, including multiple sclerosis, organ graft rejection, and graft-versus-host disease. He has 1 patent to his name.
Career Highlights
Iancu is affiliated with Universitätsklinikum Heidelberg, where he continues to work on innovative solutions in the medical field. His research has the potential to improve the quality of life for patients suffering from serious health conditions.
Collaborations
Throughout his career, Mircea Iancu has collaborated with esteemed colleagues such as Peter Terness and Gerhard Opelz. These partnerships have enhanced the scope and impact of his research.
Conclusion
Mircea Iancu's contributions to immunology through his innovative patent demonstrate his commitment to advancing medical science. His work holds promise for improving treatments for autoimmune diseases and enhancing patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile